@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:148793_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Una antraciclina, que es la 4'-epi-isómero de la doxorubicina. El compuesto ejerce sus efectos antitumorales por la interferencia con la síntesis y función del ADN."@es, "An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA."@en ;
  dc:source "Medical Subject Headings 2011" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:148793
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2011-10-06"^^xsd:date ;
  dc:modified "2012-11-30"^^xsd:date ;
  skos:broader nalt:10464 ;
  skos:definition nalt:148793_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "epirubicin"@en, "epirubicina"@es ;
  ns0:marc001 "59674" .

nalt:10464
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:148793 ;
  skos:prefLabel "doxorrubicina"@es, "doxorubicin"@en .